XENEISOL Drug Patent Profile
✉ Email this page to a colleague
When do Xeneisol patents expire, and what generic alternatives are available?
Xeneisol is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in XENEISOL is xenon xe-133. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XENEISOL?
- What are the global sales for XENEISOL?
- What is Average Wholesale Price for XENEISOL?
Summary for XENEISOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 7 |
| Patent Applications: | 262 |
| DailyMed Link: | XENEISOL at DailyMed |
US Patents and Regulatory Information for XENEISOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt | XENEISOL | xenon xe-133 | SOLUTION;INHALATION, INJECTION | 017262-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
